We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $408M
1-Year Est. Return 38.15%
This Fund
S&P 500
This Quarter Est. Return
+7.14%
1 Year Est. Return
+38.15%
3 Year Est. Return
+99.11%
5 Year Est. Return
+126.46%
10 Year Est. Return
–
AUM
$273M
AUM Growth
+$11.5M
Cap. Flow
-$1.86M
Cap. Flow %
-0.68%
Top 10 Hldgs %
44.01%
Holding
79
New
5
Increased
7
Reduced
34
Closed
3

Top Buys

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$1.2M
2
GH icon
Guardant Health
GH
+$1.15M
3
CGON icon
CG Oncology
CGON
+$1.02M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$258K
5
MGK icon
Vanguard Morningstar Mega Cap Growth ETF
MGK
+$232K

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$1.01M
2
META icon
Meta Platforms (Facebook)
META
+$995K
3
NFLX icon
Netflix
NFLX
+$686K
4
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$252K
5
ABNB icon
Airbnb
ABNB
+$235K

Sector Composition

Rank Sector Weight
1 Communication Services 18.96%
2 Consumer Staples 15.27%
3 Healthcare 12.89%
4 Miscellaneous 12.41%
5 Technology 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNY
51
Bank of New York Mellon
BNY
$105B
$576K 0.21%
10,000
– –
XBI icon
52
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$484K 0.18%
5,103
+2,783
+120% +$258K
ROK icon
53
Rockwell Automation
ROK
$46.3B
$481K 0.18%
1,650
– –
JNJ icon
54
Johnson & Johnson
JNJ
$644B
$479K 0.18%
3,030
– –
VOO icon
55
Vanguard S&P 500 ETF
VOO
$1.04T
$472K 0.17%
982
– –
HD icon
56
Home Depot
HD
$305B
$460K 0.17%
1,200
– –
REGN icon
57
Regeneron Pharmaceuticals
REGN
$79.7B
$403K 0.15%
419
– –
CB icon
58
Chubb
CB
$132B
$393K 0.14%
1,510
– –
MSFT icon
59
Microsoft
MSFT
$3.69T
$390K 0.14%
926
– –
COST icon
60
Costco
COST
$400B
$366K 0.13%
500
– –
XYZ
61
Block Inc
XYZ
$47B
$332K 0.12%
3,930
– –
EMR icon
62
Emerson Electric
EMR
$82B
$312K 0.11%
2,749
– –
QCOM icon
63
Qualcomm
QCOM
$201B
$308K 0.11%
1,818
– –
IWD icon
64
iShares Russell 1000 Value ETF
IWD
$82.8B
$282K 0.1%
1,574
-508
-24% -$86K
JPM icon
65
JPMorgan Chase
JPM
$937B
$277K 0.1%
1,385
– –
TSM icon
66
TSMC
TSM
$2.15T
$273K 0.1%
2,000
– –
SONM icon
67
DNA X Inc
SONM
$4.49M
$252K 0.09%
2,294
– –
GOOG icon
68
Alphabet (Google) Class C
GOOG
$4.18T
$250K 0.09%
1,640
– –
MGK icon
69
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.2B
$241K 0.09%
+4,205
New +$232K
NVO
70
Novo Nordisk
NVO
$188B
$220K 0.08%
+1,700
New +$202K
MTB icon
71
M&T Bank
MTB
$34B
$218K 0.08%
1,500
– –
VONG icon
72
Vanguard Russell 1000 Growth ETF
VONG
$45.1B
$208K 0.08%
+2,396
New +$199K
SQQQ icon
73
ProShares UltraPro Short QQQ
SQQQ
$2.14B
$113K 0.04%
432
– –
LKCO
74
DELISTED
Luokung Technology Corp Ordinary Shares
LKCO
$108K 0.04%
21,172
– –
KGC icon
75
Kinross Gold
KGC
$33.3B
$95K 0.03%
15,500
– –
1 2
3
4

Similar funds

RWA
Rooted Wealth Advisors Bourbonnais, Illinois $408M AUM 18.96% 1-Year Est. Return
RPA
Rock Point Advisors Burlington, Vermont $409M AUM 30.68% 1-Year Est. Return
TAS
TIFF Advisory Services Radnor, Pennsylvania $408M AUM 20.34% 1-Year Est. Return
DI
DKRT Investments Toronto $409M AUM 14.44% 1-Year Est. Return
PCP
Polunin Capital Partners London, United Kingdom $407M AUM 55.12% 1-Year Est. Return
I
InceptionR Lafayette, California $407M AUM 25.68% 1-Year Est. Return
IFS
Ifrah Financial Services Little Rock, Arkansas $409M AUM 28.15% 1-Year Est. Return
APWM
Argonautica Private Wealth Management Wellesley, Massachusetts $409M AUM 66.94% 1-Year Est. Return

Sicart Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Sicart Associates held 79 positions worth $273M, up 4.4% from $261M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sicart Associates's Q1 2024 filing shows 5 new, 7 increased, 34 reduced and 3 closed positions. Its largest new stake was iShares Biotechnology ETF: 8,780 shares worth $1.2M. The largest sale was SPDR Gold Trust, an estimated $1.01M.

By sector, the portfolio is most concentrated in Communication Services at 19% of assets, up from 17% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Sicart Associates's largest Q1 2024 buy was iShares Biotechnology ETF: 8,780 shares worth $1.2M.
  • Sicart Associates added most to Guardant Health in Q1 2024, an estimated $1.15M increase.
  • Sicart Associates's biggest Q1 2024 reduction was SPDR Gold Trust, cutting an estimated $1.01M.
  • Sicart Associates fully exited Roblox in Q1 2024, selling an estimated $225K.
  • Sicart Associates's ten largest holdings make up 44% of its $273M portfolio in Q1 2024.
  • Sicart Associates opened 5 new positions and closed 3 in Q1 2024.
  • Sicart Associates's portfolio value rose 4.4% quarter-over-quarter to $273M.

Based on Sicart Associates's 13F filing for Q1 2024, filed 3 May 2024.